Recent studies and lawsuits have begun to focus on the alleged link between long-term Depo-Provera use and intracranial meningiomas (brain tumors). Plaintiffs assert that the manufacturer failed to adequately warn women of this risk.
In February of 2025, federal cases were consolidated into a Multi-District Litigation (MDL) in the Northern District of Florida, where the court may coordinate discovery and pretrial proceedings for greater efficiency and consistency.
Depo-Provera (medroxyprogesterone acetate) is an injected contraceptive. Recent research (such as a March 2024 BMJ study) has raised concerns about its hormonal effects increasing the risk of intracranial meningioma, especially with prolonged use in some women.
Meningiomas are typically benign tumors of the membranes around the brain and spinal cord.
Individuals who may have valid legal claims include:
Meningiomas can cause serious neurological symptoms and require extensive medical care. Possible consequences include:
If you believe your tumor may be linked to Depo-Provera:
© 2020 | HD Video & Web by VideoEnvy
The Law Offices of Foster & Houston, PLLC | Ryan Foster, Attorney
500 North Capital of Texas Hwy, Building 2, Austin, Texas 78746
Toll Free Phone Number: 877-377-5411
While we retain joint responsibility, most cases of this nature are referred to other attorneys for principal responsibility.